Dr. Alireza Khadem

Christos Gougoulias (Innovad)     Modern poultry broiler production strives for the maximum live weight, which can contribute to chronic intestinal inflammation and broader metabolic syndromes. There is thus a need to establish realistic models that help the industry. Several challenge models have been proposed by the scientific community and these include biological agents or patho ...

INTRODUCTIONAntibiotics used as growth promoters (AGP) have successfully controlled dysbiosis and enteropathogens for the past 50 years (1). However, the recent increase in worldwide non-AGP poultry production is challenging the industry in management, health, and animal welfare due to the increase of enteric and systemic diseases (2, 3). One of the most accepted theories of AGP mechanism is its r ...

Highlights of this researchChronic Inflammation means losses and can cause a reduction in growth up to 30%Chronic gut inflammation often seen in field conditions is due to the synergistic & additive negative impact of several stress factors.We triggered ‘chronic gut inflammation’ with the complete replacement of corn with wheat and ryeLumance® alleviated ‘chronic gut infl ...

IntroductionAntibiotics and pharmacological levels of ZnO are common recommendations for prevention of PWD and improvement of growth performance in farms (1). The EC has scheduled a ban on ZnO as of 2022 and increasing incidence of AMR requires restrictive and prudent use (2).This study investigated the effectiveness of an in-feed complex alternative formula of esterified butyrins, medium chain fa ...

IntroductionEarlier, it was hypothesized that growth promoting effects of Antimicrobial Growth Promoters (AGPs) in poultry feed are attributed to their non-antibiotic anti-inflammatory properties.Inflammation causes a reduction in growth (through inappetence and muscle catabolism), birds without any inflammation can reach 100 % of their genetic growth potential.Among the proposed anti-inflammatory ...